Adipose tissue thermogenesis pathway

The adipose tissue thermogenesis pathway comprises the cellular processes by which brown and beige adipocytes generate heat through non-shivering thermogenesis. Core molecular components include the β3-adrenergic receptor, which is activated by norepinephrine released by sympathetic nerves upon cold exposure, leading to increased intracellular cAMP, protein kinase A (PKA) activation, and stimulation of uncoupling protein 1 (UCP1), a mitochondrial proton transporter responsible for dissipating the proton gradient as heat instead of ATP. Additional transcriptional regulators such as PGC-1α and Prdm16 orchestrate the mitochondrial biogenesis and gene expression required for thermogenic capacity. The pathway also encompasses creatine and calcium cycling as UCP1-independent thermogenic mechanisms. Therapeutic targeting of this pathway is considered promising for metabolic disease treatment, though direct targeting is complicated by the risk of cardiovascular side effects and the complexity of human adipose biology. In summary: The "Adipose tissue thermogenesis pathway" refers to a biological process, not a discrete molecular drug target, though its molecular components (e.g., UCP1, β3-adrenergic receptor) are established drug targets for obesity and metabolic diseases[1][2][3][6][7].

Other names

Thermogenic adipose pathwayBrown adipose tissue thermogenesis pathwayBeige adipose tissue thermogenesis

Activation of β3-adrenergic receptor to stimulate cAMP signaling and UCP1 expression. PPAR-γ agonists promote browning of white adipose tissue via Prdm16, enhancing thermogenic gene expression. Increased lipolysis and fatty acid oxidation, fueling mitochondrial uncoupling through UCP1.